el-Assal O N, Yamanoi A, Soda Y, Yamaguchi M, Yu L, Nagasue N
Second Department of Surgery, Shimane Medical University, Izumo, Japan.
Surgery. 1997 Sep;122(3):571-7. doi: 10.1016/s0039-6060(97)90130-6.
Hepatocellular carcinoma (HCC) is one of the most malignant human tumors and is associated with a high incidence of postoperative recurrence. There is no generally accepted definition for HCC invasiveness. Moreover, the predictive value of the pathologic factors that reflect HCC invasiveness was previously studied as separate events, with much controversy among different study groups. In this study, we proposed an invasiveness scoring system based on the relative importance of six criteria for HCC invasiveness: portal vein invasion, intrahepatic metastasis, hepatic vein invasion, serosal invasion, absence of tumor capsule, or presence of capsular invasion.
A total of 137 patients (111 male and 26 female) who underwent curative hepatectomy for HCC were included. Scoring of the six pathologic parameters was based on the clinical significance of each parameter as a single predictor for recurrence after curative resection. According to our scoring system, the patients were divided into three groups: low invasive HCC group A with a total invasiveness score 0 to 1, moderately invasive group B with a score of 2 to 4, and highly invasive group C with a total score of 5 or greater (5 to 11 points).
Evaluation of the current scoring system showed a significant stepwise increase in the incidence of recurrence as the invasiveness score increased. Moreover, disease-free survival was significantly different among the three groups (log rank p < 0.0001). The 1-, 3-, 5-, and 8-year disease-free survival rates were 89%, 59%, 54%, and 54% in group A; 72%, 32%, 12%, and 10% in group B; and 54%, 19%, 7%, and 0 in group C, respectively. Multivariate analysis showed that the patients of groups B and C had a significantly worse prognosis compared with those of group A (p < 0.0001).
The current scoring system can classify HCCs into three invasive categories and predict more accurately recurrence and disease-free survival after curative hepatectomy compared with any single invasive parameter previously proposed. Moreover, this system can be used as a therapeutic guide during and after the surgical decision making.
肝细胞癌(HCC)是人类最恶性的肿瘤之一,且术后复发率高。目前尚无被广泛接受的HCC侵袭性定义。此外,以往对反映HCC侵袭性的病理因素的预测价值是单独进行研究的,不同研究组之间存在诸多争议。在本研究中,我们基于HCC侵袭性的六个标准的相对重要性提出了一种侵袭性评分系统:门静脉侵犯、肝内转移、肝静脉侵犯、浆膜侵犯、无肿瘤包膜或有包膜侵犯。
共纳入137例行HCC根治性肝切除术的患者(男性111例,女性26例)。六个病理参数的评分基于每个参数作为根治性切除术后复发单一预测指标的临床意义。根据我们的评分系统,患者被分为三组:侵袭性低的A组,总侵袭性评分为0至1分;侵袭性中等的B组,评分为2至4分;侵袭性高的C组,总分5分或更高(5至11分)。
对当前评分系统的评估显示,随着侵袭性评分增加,复发率呈显著逐步上升。此外,三组之间的无病生存期有显著差异(对数秩检验p<0.0001)。A组1年、3年、5年和8年的无病生存率分别为89%、59%、54%和54%;B组分别为72%、32%、12%和10%;C组分别为54%、19%、7%和0。多因素分析显示,B组和C组患者的预后明显比A组差(p<0.0001)。
与之前提出的任何单一侵袭性参数相比,当前评分系统可将HCC分为三类侵袭性类型,并能更准确地预测根治性肝切除术后的复发和无病生存期。此外,该系统可在手术决策过程中和术后用作治疗指导。